🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vishwas Paralkar

Melinta Therapeutics (United States)

ORCID: 0000-0003-2852-6533

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity”.

Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity

NAR Cancer(2021)10.1093/narcan/zcab021

N/A

0DataRank · unranked

30 citations

Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold, Patricia Bourassa +19 more

Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’

NAR Cancer(2021)10.1093/narcan/zcab047

N/A

0DataRank · unranked

1 citations

Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold, Patricia Bourassa +19 more

TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-1000

N/A

0DataRank · unranked

55 citations

Yasuhisa Murai, Keli Agama, Yilun Sun, Liton Kumar Saha, Xi Yang +11 more